DK1756310T3 - Fremgangsmåde til at påvise polymorfi i ABCB1-genet associeret med mangel af respons for et CNS-aktivt lægemiddel samt lægemiddel omfattende en ABCB1-inhibitor til anvendelse i behandlingen af CNS-relaterede sygdomme - Google Patents

Fremgangsmåde til at påvise polymorfi i ABCB1-genet associeret med mangel af respons for et CNS-aktivt lægemiddel samt lægemiddel omfattende en ABCB1-inhibitor til anvendelse i behandlingen af CNS-relaterede sygdomme

Info

Publication number
DK1756310T3
DK1756310T3 DK05748517.9T DK05748517T DK1756310T3 DK 1756310 T3 DK1756310 T3 DK 1756310T3 DK 05748517 T DK05748517 T DK 05748517T DK 1756310 T3 DK1756310 T3 DK 1756310T3
Authority
DK
Denmark
Prior art keywords
cns
abcb1
drug
lack
response
Prior art date
Application number
DK05748517.9T
Other languages
English (en)
Inventor
Florian Holsboer
Elisabeth Binder
Bertram Mueller-Myhsok
Manfred Uhr
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of DK1756310T3 publication Critical patent/DK1756310T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK05748517.9T 2004-05-12 2005-05-12 Fremgangsmåde til at påvise polymorfi i ABCB1-genet associeret med mangel af respons for et CNS-aktivt lægemiddel samt lægemiddel omfattende en ABCB1-inhibitor til anvendelse i behandlingen af CNS-relaterede sygdomme DK1756310T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57008504P 2004-05-12 2004-05-12
PCT/EP2005/005194 WO2005108605A2 (en) 2004-05-12 2005-05-12 Polymorphisms in abcb1 associated with a lack of clinical response to medicaments

Publications (1)

Publication Number Publication Date
DK1756310T3 true DK1756310T3 (da) 2013-03-18

Family

ID=34979627

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05748517.9T DK1756310T3 (da) 2004-05-12 2005-05-12 Fremgangsmåde til at påvise polymorfi i ABCB1-genet associeret med mangel af respons for et CNS-aktivt lægemiddel samt lægemiddel omfattende en ABCB1-inhibitor til anvendelse i behandlingen af CNS-relaterede sygdomme

Country Status (6)

Country Link
US (1) US8030033B2 (da)
EP (1) EP1756310B1 (da)
DK (1) DK1756310T3 (da)
ES (1) ES2397345T3 (da)
PL (1) PL1756310T3 (da)
WO (1) WO2005108605A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2041312B1 (en) 2006-07-14 2010-12-01 The Govt. of the USA as Represented by the Secretary of the Dept. of Health and Human Services Abcbi genotyping to predict microtubule-stabilizing-agent-induced toxicity
EP2520670B1 (en) 2007-06-12 2014-02-26 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. New polymorphisms in ABCB1 associated with a lack of clinical response to medicaments
EP2670866A4 (en) * 2011-04-05 2015-09-02 Translational Genomics Res Inst BIOMARKERS AND METHODS OF USE
CN108929913A (zh) * 2018-08-21 2018-12-04 潍坊德诺泰克生物科技有限公司 用于检测rs2032582的引物探针组及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL354034A1 (en) 1999-07-30 2003-12-15 EPIDAUROS Biotechnologie AktiengesellschaftEPIDAUROS Biotechnologie Aktiengesellschaft Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
US7034036B2 (en) 2000-10-30 2006-04-25 Pain Therapeutics, Inc. Inhibitors of ABC drug transporters at the blood-brain barrier
US20050069936A1 (en) * 2003-09-26 2005-03-31 Cornelius Diamond Diagnostic markers of depression treatment and methods of use thereof

Also Published As

Publication number Publication date
ES2397345T3 (es) 2013-03-06
EP1756310A2 (en) 2007-02-28
US20080064609A1 (en) 2008-03-13
EP1756310B1 (en) 2012-12-05
US8030033B2 (en) 2011-10-04
WO2005108605A2 (en) 2005-11-17
PL1756310T3 (pl) 2013-05-31
WO2005108605A3 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
CY2016009I1 (el) Ενωσεις για την αναστολη του ενζυμου πρωτεασωματος
DK1718967T3 (da) Metoder til at detektere Lp-PLA2 aktivitet
DK1664345T3 (da) OLA-baserede fremgangsmåder til detektion af target-nukleinsyresekvenser
DK2046819T3 (da) Fremgangsmåder til forøgelse af secernering af polypeptider med biologisk aktivitet
DK1718608T3 (da) Virale polymeraseinhibitorer
DE602005017393D1 (de) Flüssigkeitszerstäubungssystem und -verfahren
DE602005027253D1 (de) Herbizidresistenz verleihende gene
DK1966393T3 (da) Fremgangsmåde til AFLP-baseret påvisning af polymorfisme med høj omsætning
DK2158331T3 (da) Nye polymorfier i ABCB1 i sammenhæng med mangel på klinisk respons over for lægemidler
EP2083843A4 (en) MULTIFUNCTIONAL SUPPORTS FOR THE ADMINISTRATION OF NUCLEIC ACIDS AND METHOD OF USE THEREOF
FI20060833A (fi) Lämmönvaihdinpolymerointireaktoreita vastusta pienentävien aineiden valmistamiseksi
DK2418201T3 (da) Polymorfe former af (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin) yl]-4-penten-2-amin p-hydroxybenzoat til behandling af centralnervesystemlidelser
DE602004030756D1 (de) Flüssigkeits-Kühlsystem
GB2410557B (en) Liquid level sensing apparatus
DK1756310T3 (da) Fremgangsmåde til at påvise polymorfi i ABCB1-genet associeret med mangel af respons for et CNS-aktivt lægemiddel samt lægemiddel omfattende en ABCB1-inhibitor til anvendelse i behandlingen af CNS-relaterede sygdomme
DK1694858T3 (da) Fremgangsmåde til påvisning af patogene mykobakterier i kliniske pröver
DE602005006790D1 (de) Vorrichtung zum umdrehen von sich bewegenden flaschen
DK2270227T3 (da) Oligonukleotider, rækker deraf til påvisning af mikroorganismer samt apparat, fremgangsmåde og sæt til påvisning af mikroorganismer
DK1635820T3 (da) Asenapin til behandling af skizofreni hos en patient med overvægt eller tilböjelighed til overvægt
SE0701842L (sv) Raffineringsplåtsegment med triangulärt inloppssärdrag
WO2008048639A3 (en) Genetic prediction of schizophrenia susceptibility
DE602005014475D1 (de) Nukleinsäure/enzym-komplex
DK1807532T3 (da) Fremgangsmåder med anvendelse af mitokondrie-nukleinsyre til bestemmelse af et individs sundhedstilstand
ITTO20060063A1 (it) Corredo per l'amplificazione di acidi nucleici.
FR2881203B1 (fr) Dispositif de prise en charge hydraulique et methode de prise en charge correspondante